Brief: BioInvent Publishes Preclinical Manuscript On BI-1808, BI-1910
20/08/2026 13:06
BRIEF-BioInvent Publishes Preclinical Manuscript On BI-1808, BI-1910 Aug 20 (Reuters) - BioInvent International AB BINV.ST:
ANNOUNCES PUBLICATION OF PRECLINICAL MANUSCRIPT ON BI-1808 AND BI-1910
BI-1808 DEMONSTRATES ANTITUMOR IMMUNITY IN TUMORS RESISTANT TO IMMUNE CHECKPOINT BLOCKADE
BI-1808 BEING EVALUATED IN ONGOING PHASE 2A CLINICAL TRIALS
BI-1910 DEVELOPMENT CURRENTLY PAUSED; ANTIBODY CO-STIMULATES T AND NK CELLS
Source text: ID:nMFN6KrkD9
Further company coverage: BINV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))